(S (NP (PRP We)) (VP (VBD explored) (SBAR (WHADVP (WRB how)) (S (NP (NP (DT the) (NN knowledge) (NN translation)) (CC and) (NP (NN innovation) (NNS processes))) (VP (VBP are) (VP (VBN structured) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP result) (PP (IN in) (NP (NNS innovations))) (, ,) (PP (IN as) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (JJ liposomal) (NN doxorubicin) (NN research)))))))))))))) (. .))
(S (PP (IN In) (NP (NN order) (S (VP (TO to) (VP (VB map) (NP (DT the) (NNS processes))))))) (, ,) (S (NP (DT a) (NN literature) (NN network) (NN analysis)) (VP (VBD was) (VP (VBN made) (PP (IN through) (NP (NNP Cytoscape)))))) (CC and) (S (NP (JJ semantic) (NN analysis)) (VP (VBD was) (VP (VBN performed) (PP (IN by) (NP (NP (NNP GOPubmed)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (VP (VBN based) (PP (IN in) (NP (NP (DT the) (VBN controlled) (NNS vocabularies) (NN MeSH)) (-LRB- -LRB-) (NP (JJ Medical) (NN Subject) (NNS Headings)) (-RRB- -RRB-))))) (CC and) (VP (VB GO))))))) (PRN (-LRB- -LRB-) (NP (NNP Gene) (NNP Ontology)) (-RRB- -RRB-))))) (. .))
(S (S (NP (PRP We)) (VP (VBD found) (NP (NP (NNS clusters)) (VP (VBN related) (PP (IN to) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NP (NP (DT the) (JJ technological) (NN development)) (-LRB- -LRB-) (NP (NN invention) (, ,) (NN innovation) (CC and) (NN imitation)) (-RRB- -RRB-)) (CC and) (NP (DT the) (NML (NN knowledge) (NN translation)) (NN process)))))))) (PRN (-LRB- -LRB-) (NP (NP (JJ preclinical) (, ,) (JJ translational)) (CC and) (NP (JJ clinical) (NN research))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB map) (NP (NP (DT the) (JJ historic) (NN emergence)) (PP (IN of) (NP (NNP Doxil)))) (PP (IN as) (NP (DT a) (JJ paradigmatic) (NN nanodrug))))))))) (. .))
(S (NP (DT This) (NN research)) (VP (MD could) (VP (VB be) (NP (NP (NP (DT a) (JJ powerful) (JJ methodological) (NN tool)) (PP (IN for) (NP (NN decision) (HYPH -) (NN making)))) (CC and) (NP (NP (NN innovation) (NN management)) (PP (IN in) (NP (NML (NN drug) (NN delivery)) (NN research))))))) (. .))
